santos.argonowta's Top FindsLoading...
Everything You Ever Wanted to Know About Type II Restriction Enzymes
neb.com·1d·
Discuss: Hacker News
Flag this post
Craft Revival
elmerdata.bearblog.dev·8h
Flag this post
The AI Boom Is Fueling a Need for Speed in Chip Networking
wired.com·17h
Flag this post
💡 WiseUp! Vol. 41 — Is your mind well-stocked?
wiseup.readwise.io·13h
Flag this post
Cognitive Automation: Unleashing the Autonomous Enterprise Brain
pub.towardsai.net·15h
Flag this post
How to stop having FOMO as a curious engineer: hold a thread
yacinemahdid.com·1d·
Discuss: Hacker News
Flag this post
Autoimmune AI Apocalypse
1a3orn.com·2h·
Discuss: Hacker News
Flag this post
Controlling mass and energy diffusion with metamaterials
link.aps.org·17h
Flag this post
Falling asleep isn’t a gradual process – it happens all of a sudden
newscientist.com·2d·
Discuss: Hacker News
Flag this post
Is anger the secret fuel for your next big idea? A new study suggests it could help
nordot.app·17h
Flag this post
Building a Social Network Analyzer with CXXGraph: From Friend Recommendations to Influence Detection
dev.to·23h·
Discuss: DEV
Flag this post
Fluence Map Prediction with Deep Learning: A Transformer-based Approach
arxiv.org·5h
Flag this post
FaithAct: Faithfulness Planning and Acting in MLLMs
arxiv.org·1d
Flag this post
As we delve into the realm of quantum machine learning (QML)
dev.to·3d·
Discuss: DEV
🧠Neuro- Chemistry
Flag this post
Versatile and Risk-Sensitive Cardiac Diagnosis via Graph-Based ECG Signal Representation
arxiv.org·1d
Flag this post
Unlocking AI Reasoning: The Power of Hierarchical Skipping
dev.to·21h·
Discuss: DEV
Flag this post
RS-Net: Context-Aware Relation Scoring for Dynamic Scene Graph Generation
arxiv.org·5h
Flag this post
AD-DAE: Unsupervised Modeling of Longitudinal Alzheimer's Disease Progression with Diffusion Auto-Encoder
arxiv.org·2d
Flag this post
Reinforcement Learning Improves Traversal of Hierarchical Knowledge in LLMs
arxiv.org·2d
🧠Neuro- Chemistry
Flag this post
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
prnewswire.com·21h
Flag this post